Direct-to-the-consumer advertising of drug products.
Direct-to-the consumer advertising of prescription drug products is increasingly scrutinized by the federal Food and Drug Administration, spurred in part by growing concern about the potential for abuse posed by such advertising in the absence of effective regulation. Drug industry officials claim they are providing the public with valuable information, but many physicians and health care professionals are distressed by the new trend.